Oleclumab (INN; development code MEDI9447) is a human monoclonal antibody targeting the ectonucleotidase CD73 that was designed for the treatment of pancreatic...
2 KB (76 words) - 19:23, 20 December 2023
Lirentelimab Lirilumab Mavrilimumab Metelimumab Morolimumab Namilumab Oleclumab Oxelumab§ Pamrevlumab Placulumab Relatlimab† Sarilumab Sifalimumab Tabalumab...
38 KB (4,316 words) - 10:24, 26 August 2024
leukemia, multiple sclerosis Olaratumab Lartruvo mab human PDGFRA Y cancer Oleclumab mab human 5'-nucleotidase pancreatic and colorectal cancer Olendalizumab...
137 KB (4,083 words) - 21:25, 19 October 2024
Lirentelimab Lirilumab Mavrilimumab Metelimumab Morolimumab Namilumab Oleclumab Oxelumab§ Pamrevlumab Placulumab Relatlimab† Sarilumab Sifalimumab Tabalumab...
2 KB (87 words) - 01:28, 30 May 2023